383.06
Overview
News
Price History
Option Chain
Financials
Why SYK Down?
Discussions
Forecast
Stock Split
Dividend History
Stryker Corp stock is traded at $383.06, with a volume of 1.35M.
It is down -1.36% in the last 24 hours and up +2.55% over the past month.
Stryker designs, manufactures, and markets an array of medical equipment, instruments, consumable supplies, and implantable devices. The product portfolio includes hip and knee replacements, extremities, endoscopy systems, operating room equipment, embolic coils, hospital beds and gurneys, and orthopedic robotics. Stryker remains one of the three largest competitors in reconstructive orthopedic implants and holds the leadership position in operating room equipment. Roughly one-fourth of Stryker's total revenue currently comes from outside the United States.
See More
Previous Close:
$388.35
Open:
$387
24h Volume:
1.35M
Relative Volume:
1.04
Market Cap:
$146.45B
Revenue:
$23.82B
Net Income/Loss:
$2.92B
P/E Ratio:
50.69
EPS:
7.5574
Net Cash Flow:
$4.02B
1W Performance:
+3.74%
1M Performance:
+2.55%
6M Performance:
+7.27%
1Y Performance:
+5.46%
Stryker Corp Stock (SYK) Company Profile
Name
Stryker Corp
Sector
Industry
Phone
(269) 385-2600
Address
1941 STRYKER WAY, PORTAGE, MI
Compare SYK with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
|
SYK
Stryker Corp
|
383.06 | 145.19B | 23.82B | 2.92B | 4.02B | 7.5574 |
|
ABT
Abbott Laboratories
|
126.34 | 221.98B | 43.84B | 13.94B | 6.78B | 7.9979 |
|
BSX
Boston Scientific Corp
|
102.39 | 148.03B | 19.35B | 2.78B | 3.49B | 1.8696 |
|
MDT
Medtronic Plc
|
94.21 | 122.92B | 34.20B | 4.69B | 5.30B | 3.6218 |
|
EW
Edwards Lifesciences Corp
|
76.53 | 44.63B | 5.69B | 1.41B | 577.90M | 6.9828 |
Stryker Corp Stock (SYK) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-18-25 | Initiated | Rothschild & Co Redburn | Neutral |
| Feb-26-25 | Resumed | Citigroup | Buy |
| Dec-02-24 | Upgrade | Morgan Stanley | Equal-Weight → Overweight |
| Sep-10-24 | Initiated | Wolfe Research | Outperform |
| May-30-24 | Initiated | Goldman | Neutral |
| May-22-24 | Upgrade | Needham | Hold → Buy |
| Jan-31-24 | Upgrade | Canaccord Genuity | Hold → Buy |
| Oct-20-23 | Initiated | ROTH MKM | Buy |
| Sep-05-23 | Upgrade | BofA Securities | Neutral → Buy |
| Mar-29-23 | Initiated | UBS | Neutral |
| Jan-25-23 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jan-09-23 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Nov-01-22 | Downgrade | Canaccord Genuity | Buy → Hold |
| Oct-18-22 | Initiated | Barclays | Overweight |
| Oct-12-22 | Initiated | Jefferies | Buy |
| Jul-28-22 | Upgrade | Edward Jones | Hold → Buy |
| Jul-21-22 | Downgrade | Deutsche Bank | Buy → Hold |
| Jul-11-22 | Downgrade | BofA Securities | Buy → Neutral |
| Apr-13-22 | Initiated | Truist | Hold |
| Mar-16-22 | Upgrade | Bernstein | Mkt Perform → Outperform |
| Mar-15-22 | Resumed | Evercore ISI | Outperform |
| Mar-02-22 | Resumed | BofA Securities | Buy |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Jan-04-22 | Upgrade | Piper Sandler | Neutral → Overweight |
| Dec-10-21 | Initiated | RBC Capital Mkts | Sector Perform |
| Dec-07-21 | Initiated | Loop Capital | Buy |
| Sep-14-21 | Resumed | Raymond James | Mkt Perform |
| Jul-28-21 | Upgrade | Northland Capital | Market Perform → Outperform |
| Jun-01-21 | Upgrade | Evercore ISI | In-line → Outperform |
| May-25-21 | Initiated | Barclays | Underweight |
| Oct-06-20 | Initiated | Northland Capital | Market Perform |
| Sep-11-20 | Initiated | Wolfe Research | Peer Perform |
| Apr-13-20 | Downgrade | Barclays | Equal Weight → Underweight |
| Apr-01-20 | Downgrade | Goldman | Buy → Sell |
| Mar-05-20 | Initiated | Citigroup | Buy |
| Feb-13-20 | Initiated | Goldman | Buy |
| Jan-08-20 | Initiated | SunTrust | Hold |
| Jan-07-20 | Downgrade | Piper Jaffray | Overweight → Neutral |
| Jan-07-20 | Downgrade | Piper Sandler | Overweight → Neutral |
| Dec-30-19 | Reiterated | BTIG Research | Buy |
| Nov-05-19 | Downgrade | Barclays | Overweight → Equal Weight |
| Oct-30-19 | Reiterated | BofA/Merrill | Buy |
| Jul-02-19 | Downgrade | Evercore ISI | Outperform → In-line |
| Jan-30-19 | Reiterated | Canaccord Genuity | Buy |
| Jan-03-19 | Initiated | Deutsche Bank | Buy |
| Jan-02-19 | Upgrade | Evercore ISI | In-line → Outperform |
| Oct-16-18 | Initiated | Barclays | Overweight |
| Aug-16-18 | Initiated | BTIG Research | Buy |
| Jun-27-18 | Initiated | Bernstein | Mkt Perform |
| Apr-27-18 | Reiterated | Stifel | Buy |
View All
Stryker Corp Stock (SYK) Latest News
Will Stryker Corporation stock gain from strong economyJuly 2025 Short Interest & Entry Point Confirmation Alerts - newser.com
Is Stryker Corporation (SYK) stock supported by strong fundamentalsJuly 2025 Patterns & Real-Time Volume Trigger Notifications - newser.com
Is Stryker Corporation (SYK) stock cheap vs fundamentals2025 Pullback Review & Daily Stock Trend Reports - newser.com
Why Stryker Corporation stock remains top rated2025 Price Momentum & Long-Term Safe Return Strategies - newser.com
GCC $1.25+ Bn Catheter Market Growth Trends and Forecast to 2033 Featuring Abbott, Edwards Lifesciences, BD and Co, Boston Scientific, Medtronic, Johnson & Johnson, Stryker, Teleflex - Yahoo Finance
United States Breast Reconstruction Market Growth Trends and Forecast Report 2025-2033, Profiles of Mentor Worldwide, AbbVie, Integra, Sientra, Stryker, Establishment Labs, RTI Surgical, TELA Bio - GlobeNewswire Inc.
Is Stryker Corporation stock ready for breakoutQuarterly Market Summary & AI Forecast for Swing Trade Picks - newser.com
Stryker Corporation's (NYSE:SYK) Fundamentals Look Pretty Strong: Could The Market Be Wrong About The Stock? - 富途牛牛
Stryker (SYK) Receives Overweight Rating and Raised Price Target from Barclays | SYK Stock News - GuruFocus
The Zacks Analyst Blog Highlights Moodys, Stryker and CBRE - The Globe and Mail
How Stryker Corporation stock reacts to weak economyQuarterly Market Summary & Free Risk Controlled Daily Trade Plans - newser.com
Key metrics from Stryker Corporation’s quarterly dataMarket Sentiment Review & Risk Adjusted Buy/Sell Alerts - newser.com
Tumor Ablation Market Poised for Robust Growth by 2032, Driven by Technological Advancements and Rising Surgical Volumes, DelveInsight | Medtronic PLC, Stryker, Baird Medical Devices Inc., Siemens Hea - Barchart.com
Stryker Corp. Forms Death Cross, Signaling Potential Bearish Trend Ahead - Markets Mojo
Buy 3 Wide Moat Stocks to Enhance Your Portfolio Returns in Q4 - The Globe and Mail
How Stryker Corporation stock reacts to monetary easing2025 Historical Comparison & Risk Controlled Stock Pick Alerts - newser.com
Stryker Corp. stock outperforms competitors on strong trading day - MarketWatch
Stryker Breaks Above 200-Day Moving AverageBullish for SYK - Nasdaq
Is Stryker Corporation stock expanding market penetrationTrade Signal Summary & Technical Pattern Alert System - newser.com
Zacks.com featured highlights include Stryker, NVIDIA, ResMed and Ralph Lauren - The Globe and Mail
Retail Trends: Is Stryker Corporation (SYK) stock cheap vs fundamentalsMarket Activity Report & Verified Entry Point Detection - nchmf.gov.vn
How Stryker Corporation stock performs in easing cyclesWeekly Risk Report & Free Verified High Yield Trade Plans - newser.com
Stryker Is Maintained at Hold by Truist Securities - 富途牛牛
What Does Stryker’s Latest Earnings Growth Mean for Its 2025 Valuation? - Yahoo Finance
Published on: 2025-10-18 11:07:51 - nchmf.gov.vn
What You Need to Know Ahead of Stryker's Earnings Release - MSN
Risk Hedge: Why Stryker Corporation (SYK) stock could be top winnerTrade Ideas & Comprehensive Market Scan Reports - nchmf.gov.vn
Sectors Review: Will Stryker Corporation stock recover faster than peersQuarterly Growth Report & Consistent Return Investment Signals - nchmf.gov.vn
Stryker Corp (NY: SYK - FinancialContent
Why Stryker Corporation (SYK) stock stays on top picks2025 Market Trends & Growth Focused Stock Pick Reports - newser.com
Truist Securities Lowers Price Target for Stryker (SYK) | SYK St - GuruFocus
Truist Financial Maintains Stryker Corp(SYK.US) With Hold Rating, Cuts Target Price to $407 - 富途牛牛
More than 80 years: Stryker to feature T2 Alpha Humeral Nail and Pangea femur system at OTA - Stock Titan
Stryker Corporation $SYK Shares Sold by TD Asset Management Inc - MarketBeat
Stryker Corporation $SYK Stock Holdings Trimmed by Boston Trust Walden Corp - MarketBeat
BTIG Maintains Stryker Corp(SYK.US) With Buy Rating, Raises Target Price to $408 - 富途牛牛
Stryker (SYK) Price Target Raised by BTIG Analyst | SYK Stock Ne - GuruFocus
Yousif Capital Management LLC Lowers Position in Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Shares Sold by Stack Financial Management Inc - MarketBeat
Can machine learning forecast Stryker Corporation recoveryJuly 2025 Pullbacks & High Conviction Buy Zone Alerts - newser.com
Bey Douglas LLC Increases Position in Stryker Corporation $SYK - MarketBeat
Vanguard Personalized Indexing Management LLC Acquires 9,436 Shares of Stryker Corporation $SYK - MarketBeat
Johnson Investment Counsel Inc. Raises Position in Stryker Corporation $SYK - MarketBeat
Sivik Global Healthcare LLC Increases Stake in Stryker Corporation $SYK - MarketBeat
Stryker Corporation $SYK Position Boosted by L. Roy Papp & Associates LLP - MarketBeat
Coordinated Financial Services Inc. Takes Position in Stryker Corporation $SYK - MarketBeat
Aberdeen Group plc Lowers Position in Stryker Corporation $SYK - MarketBeat
Callan Family Office LLC Has $3.48 Million Holdings in Stryker Corporation $SYK - MarketBeat
Stryker Corp. stock underperforms Friday when compared to competitors - MarketWatch
Blair William & Co. IL Lowers Position in Stryker Corporation $SYK - MarketBeat
Columbus Macro LLC Acquires 769 Shares of Stryker Corporation $SYK - MarketBeat
Stryker Corp Stock (SYK) Financials Data
Revenue
Net Income
Cash Flow
EPS
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):